Oncostrata Ltd
07348863
Healthy
No risk factors detected.
Details
Compliance
Last accounts
31/05/2025
micro entity
Next accounts due
28/02/2027
Confirmation statement
Last: 18/09/2025
Due 02/10/2026
Industry
Officers
Persons with Significant Control
Dr Joanna Hanks
British · England · Age 48
15, Aldersbrook Road, London, E12 5HH
Notified 14/10/2016
Mr Mark Hanks
British · England · Age 47
London Bioscience Innovation Centre, 2 Royal College Street, London, NW1 0NH
Notified 14/10/2016
CompanyRankvs 1370+ SIC 72110 peers54
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/05/2025
Net Worth
£156k
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
£117k
Working capital
Current Assets
£253k
Current Liabilities
—
Fixed Assets
£40k
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | — | -£29k |
| 2024 | 1.90 | +£121k |
| 2023 | 1.41 | -£83k |
| 2022 | 3.31 | -£51k |
| 2021 | 2.88 | +£102k |
| 2020 | 4.44 | +£11k |
| 2019 | 3.22 | — |
Derived from filed accounts. Not audited figures.